Kyung Dong Pharmaceutical Co., Ltd. (KOSDAQ:011040)
South Korea
· Delayed Price · Currency is KRW 5,330.00
-170.00 (-3.09%)
At close: Mar 9, 2026
Kyung Dong Pharmaceutical Ratios and Metrics
Market cap in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 6, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Market Capitalization | 143,600 | 165,153 | 179,354 | 213,543 | 313,540 | 310,369 | Upgrade
|
| Market Cap Growth | -9.04% | -7.92% | -16.01% | -31.89% | 1.02% | 65.50% | Upgrade
|
| Enterprise Value | 149,430 | 175,958 | 152,976 | 187,326 | 269,370 | 225,665 | Upgrade
|
| Last Close Price | 5330.00 | 5828.03 | 5986.55 | 6707.81 | 9285.39 | 8706.25 | Upgrade
|
| PE Ratio | 17.35 | 30.19 | - | 17.56 | 24.74 | 24.91 | Upgrade
|
| Forward PE | - | 12.11 | 12.11 | 12.11 | 12.11 | 12.11 | Upgrade
|
| PS Ratio | 0.74 | 0.85 | 1.10 | 1.17 | 1.77 | 1.79 | Upgrade
|
| PB Ratio | 0.66 | 0.75 | 0.79 | 0.83 | 1.21 | 1.18 | Upgrade
|
| P/TBV Ratio | 0.68 | 0.77 | 0.81 | 0.84 | 1.22 | 1.19 | Upgrade
|
| P/FCF Ratio | 12.40 | - | - | - | 36.90 | - | Upgrade
|
| P/OCF Ratio | 6.97 | - | - | - | 25.24 | 18.13 | Upgrade
|
| EV/Sales Ratio | 0.77 | 0.91 | 0.94 | 1.02 | 1.52 | 1.30 | Upgrade
|
| EV/EBITDA Ratio | 13.45 | 21.88 | - | 12.48 | 11.83 | 8.52 | Upgrade
|
| EV/EBIT Ratio | 21.19 | 67.07 | - | 22.54 | 17.09 | 11.45 | Upgrade
|
| EV/FCF Ratio | 12.90 | - | - | - | 31.70 | - | Upgrade
|
| Debt / Equity Ratio | 0.14 | 0.18 | 0.07 | 0.10 | 0.02 | 0.01 | Upgrade
|
| Debt / EBITDA Ratio | 2.68 | 4.81 | - | 1.79 | 0.19 | 0.07 | Upgrade
|
| Debt / FCF Ratio | 2.63 | - | - | - | 0.51 | - | Upgrade
|
| Net Debt / Equity Ratio | 0.03 | 0.04 | -0.07 | -0.07 | -0.18 | -0.23 | Upgrade
|
| Net Debt / EBITDA Ratio | 0.49 | 0.97 | 0.87 | -1.22 | -2.01 | -2.25 | Upgrade
|
| Net Debt / FCF Ratio | 0.48 | -0.49 | 2.64 | 1.57 | -5.38 | 5.19 | Upgrade
|
| Asset Turnover | 0.67 | 0.65 | 0.54 | 0.61 | 0.61 | 0.60 | Upgrade
|
| Inventory Turnover | 1.75 | 2.02 | 2.27 | 2.90 | 2.71 | 2.76 | Upgrade
|
| Quick Ratio | 0.61 | 0.70 | 0.89 | 1.41 | 2.82 | 3.07 | Upgrade
|
| Current Ratio | 1.34 | 1.29 | 1.52 | 2.05 | 4.07 | 4.22 | Upgrade
|
| Return on Equity (ROE) | 3.79% | 2.43% | -8.53% | 4.68% | 4.83% | 5.17% | Upgrade
|
| Return on Assets (ROA) | 1.57% | 0.55% | -5.17% | 1.73% | 3.38% | 4.25% | Upgrade
|
| Return on Invested Capital (ROIC) | 3.09% | 1.19% | -11.06% | 2.47% | 5.17% | 7.07% | Upgrade
|
| Return on Capital Employed (ROCE) | 3.30% | 1.20% | -10.70% | 3.20% | 5.90% | 7.40% | Upgrade
|
| Earnings Yield | 5.76% | 3.31% | -11.55% | 5.70% | 4.04% | 4.01% | Upgrade
|
| FCF Yield | 8.07% | -9.50% | -3.52% | -5.46% | 2.71% | -3.70% | Upgrade
|
| Dividend Yield | 5.45% | 5.15% | - | 5.96% | 5.38% | 5.74% | Upgrade
|
| Payout Ratio | 97.64% | 198.43% | - | 89.58% | 109.17% | 94.87% | Upgrade
|
| Buyback Yield / Dilution | 0.34% | 0.57% | 0.27% | 1.14% | -12.18% | -3.62% | Upgrade
|
| Total Shareholder Return | 5.79% | 5.71% | 0.27% | 7.11% | -6.79% | 2.12% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.